openPR Logo
Press release

Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market

08-08-2017 08:34 AM CET | Health & Medicine

Press release from: ReportsWorldwide

Benign Prostatic Hyperplasia and Prostatitis Devicebased

ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports.

This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.

Topics Covered Include:

An overview of device-based and pharmacological therapies for BPH and prostatitis.
Global and country/region-specific market forecasts, including forecasts by product segment.
Competitive analyses by product segment.
Discussion of key drivers and limiters to the BPH and prostatitis device-based treatments market.
Emerging therapies and their potential impact on the market for device-based treatments

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/benign-prostatic-hyperplasia-and-prostatitis-devicebased-treatments-market

Report Highlights:
Symptomatic BPH and prostatitis affect over 100 million men worldwide, resulting in painful symptoms and lower quality of life.
Laser-based devices and urethral implants are expected to be the primary segments driving growth in the market.
The market for devices used to treat symptomatic BPH and prostatitis is anticipated to experience moderate growth during the forecast period (2016-21), increasing to an estimated $586.1m by 2021.
Pharmaceuticals continue to play a major role in the management and treatment of symptomatic patients, with device-based therapies being restricted to use in about 10- 15% of all patients with symptomatic BPH and only the most severe cases of prostatitis.
The US market for device-based therapies currently accounts for approximately 40% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in devicebased sales is expected to occur in the US.

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41345

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market here

News-ID: 658618 • Views:

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in Regenerative Medicine
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of

More Releases for BPH

Elderly Men Creating Huge Requirement for BPH Treatment Drugs and Devices
Benign prostatic hyperplasia (BPH) or prostate gland enlargement is caused due to urinary tract infections, bladder or kidney stones, prostatitis, urethral stricture, bladder or prostate cancer, and scarring in the bladder neck caused due to previous surgeries. The common signs and symptoms of BPH include frequent urination, nocturia, difficulty in initiating urination, dribble at the end of urination, and inability to empty the bladder. This disease is highly prevalent among
Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025. Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device.
Benign Prostatic Hyperplasia (BPH) Procedures Insights, Potential Business Strat …
Increasing life expectancy and fall in the birth rates are the major reasons for rise in the aging population. The people in this category require extensive care, since they are more prone to illness due to low immunity levels and longer recovery time. Increase in the aging population in the U.S., Germany, China and India in the next few years, is expected to create high demand for BPH treatment devices,
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends, Technologica …
Benign Prostatic Hyperplasia (BPH) refers to an enlarged prostate gland. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Enlargement of prostate gland leads to blockage in urethra, thus causing problems during urination. It involves glandular and stromal epithelial hyperplasia, which occurs in the peri-urethral transition zone surrounding the urethra. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/bph-treatment-devices-market BPH is common in aging men,
Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Industry Trends …
Benign prostatic hyperplasia (BPH) is also known as benign prostatic hypertrophy or benign prostatic obstruction. Benign prostatic hyperplasia (BPH) is a health condition in men in which the prostate gland size is enlarged than a normal. In a men whole life, prostate grows in two phases, first phase is occurs in early stage of puberty, second phase starts at the age of twenty five and it continues most of persons
US Benign Prostatic Hyperplasia (BPH) Procedures - Development, Growth and Forec …
Increase in the aging population in the U.S in the next few years, is expected to create high demand for BPH treatments, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, TUIP and laser based treatments. According to the National Institute of Health, it has been estimated that around